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Abstract
Cationic lipids are being used increasingly as reagents for gene delivery both in vitro and in vivo. One of the limitations to
the application of cationic lipid^DNA complexes (lipoplexes) in vivo is the inhibition of gene delivery by serum. In this study,
we have shown that transferrin (Tf)-lipoplexes, which had transferrin adsorbed at their surface via electrostatic interactions,
are much more effective than plain lipoplexes in transfecting cells in the presence of relatively high concentrations (up to
60%) of fetal bovine serum (FBS). Serum even enhanced transfection by Tf-lipoplexes composed of 1,2-dioleoyl-3(trimethylammonium) propane (DOTAP)/dioleoylphosphatidylethanolamine (DOPE)/pCMVLacZ at high lipid/DNA (+/3)
charge ratios, and inhibited lipofection for those with low charge ratios when they were added to the cells immediately after
the preparation of complexes. The effect of serum on lipofection was dose-dependent. Preincubation of the complexes at
20³C for 6 h led to serum resistance, even for the negatively charged transferrin-lipoplexes. A similar tendency was observed
for DOTAP/cholesterol and DOTAP/DOPE/cholesterol liposomes. The percentage of cells transfected, measured by
L-galactosidase expression, also increased with the serum concentration. Cell viability was not affected significantly when the
cells were incubated with the complexes for 4 h at 37³C, followed by a 48-h incubation. Our findings extend the scope of
previous studies where transferrin-lipoplexes were used to introduce DNA into cells, rendering these complexes and their
future derivatives potential alternatives to viral vectors for gene delivery in vivo. ß 2000 Elsevier Science B.V. All rights
reserved.
Keywords: Gene therapy; Serum inhibition; Cationic liposome; Gene delivery; Transferrin; Transfection

1. Introduction
At the present time, major somatic gene transfer
approaches employ either viral [1^3] or non-viral vectors [4,5]. Viral vectors show high gene transfer e¤-
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ciency, but are de¢cient in several areas. Adenoviral
vectors induce host in£ammatory and immune responses, rendering these vectors ine¡ective in repeated application [3,6^8]. Retroviral vectors require
dividing cells for stable integration [9], making them
unsuitable for gene therapy of terminally di¡erentiated cells. Some of these problems can be circumvented by employing non-viral vehicles, such as cationic liposomes [10^16]. Synthetic cationic lipids and
the complexes they form with DNA constitute the
most promising alternative to the use of viral vectors
for gene therapy. They accomplish four goals as a
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vehicle: (1) to protect partially DNA from DNase
degradation; (2) to condense the DNA; (3) to mediate the adhesion to cells, overcoming the generally
negative polarity of most cell surfaces; and (4) to
facilitate the intracytoplasmic localization of the
DNA. A neutral co-lipid, such as dioleoylphosphatidylethanolamine (DOPE), which assumes fusogenic
properties and consequently increases the e¤ciency
of transfection, is frequently added [17,18]. It has
been suggested that the majority of DNA complexed
to cationic liposomes is taken up through endocytosis, followed by its release from an early endosomal
compartment [19^22].
In order to improve the e¤ciency of transfection
mediated by cationic liposomes, several investigators
have attempted to devise strategies to speci¢cally target, transcribe and translate DNA. As in this study,
one approach has been to introduce DNA into cells
by attaching it to a ligand and exploiting the natural
speci¢city of receptor-mediated endocytosis. This
pathway has been utilized in gene transfer studies
employing polycation^ligand conjugates [23^25].
One useful cell-binding ligand is transferrin (Tf), an
iron-transporting serum glycoprotein, which binds to
a receptor expressed on the surface of proliferating
cells, with particularly high expression on erythroblasts and tumor cells [4,26].
The ability of serum to inhibit lipofection is an
often described phenomenon [16,27^29]. In cell culture systems, liposome-mediated gene transfection is
usually carried out in serum-free medium or in at
most 10^20% serum [22,27,30^32]. The mechanism
by which serum inhibits transfection is not clear.
Interaction with polyanionic molecules or with complement [33], and low di¡usibility through the extracellular space, are obstacles to successful in vivo gene
transfer. Relatively e¤cient in vitro gene transfer in
the presence of serum was achieved by using improved formulations [27,34^36], by precondensation
of plasmid DNA with polylysine before formation of
the lipoplexes [37] or by sequential addition of the
lipid to plasmid DNA [36]. Although transferrin^
polycation conjugates have been used to target
DNA to cells [38^41], these studies were performed
either in serum-free medium or in the presence of low
concentrations of serum. A liposome formulation
with a high transfection e¤ciency that is not inhibited by high serum concentrations, would provide a

considerable advance toward the goal of systemic
delivery.
We examined whether gene transfer e¤ciency in
the presence of high concentrations of serum could
be achieved by employing receptor-mediated endocytosis. We therefore evaluated the e¡ect of increasing
amounts of serum on the levels of transfection mediated by Tf-lipoplexes, which had transferrin adsorbed at their surface via electrostatic interactions,
at di¡erent lipid/DNA (+/3) charge ratios. We also
investigated whether Tf-lipoplexes with a net negative charge could overcome the inhibitory e¡ect of
serum. It has been previously shown that these complexes, particularly at charge ratios of 0.5 and 1/1
(+/3), under which conditions they are net negatively charged, increase the transfection e¤ciency in
cell lines [42] and primary human macrophages [43].
We now report that, using transferrin in combination
with DOTAP-containing liposomes, e¤cient gene
expression can be achieved with negatively charged
lipoplexes in the presence of high concentrations of
serum.
2. Materials and methods
2.1. Materials
The cationic lipid 1,2-dioleoyl-3-(trimethylammonium) propane (DOTAP), dioleoylphosphatidylethanolamine (DOPE) and cholesterol were purchased
from Avanti Polar Lipids (Alabaster, AL, USA).
Iron-saturated, heat-inactivated human transferrin
was obtained from Collaborative Biomedical Products, Becton Dickinson (Bedford, MA, USA). The
plasmid pCMVLacZ (Clontech, Palo Alto, CA,
USA) encoding L-galactosidase was used for carrying
out the transfection studies. NaCl and N-(2-hydroxyethyl(piperazine-NP-[2-ethanesulfonic acid] (HEPES)
were obtained from Sigma (St. Louis, MO, USA).
Alamar blue dye was purchased from Accumed International (Westlake, OH, USA).
2.2. Cell culture
HeLa cells (American Type Culture Collection,
MD, USA) were maintained at 37³C under 5%
CO2 in Dulbecco's modi¢ed Eagle's medium-high
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glucose (DME-HG) (Irvine Scienti¢c, Santa Ana,
CA, USA) supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS) (Sigma, St. Louis,
MO, USA), penicillin (100 U/ml), streptomycin
(100 (g/ml) and L-glutamine (4 mM) (Irvine Scienti¢c). Cells were passaged 1:10 by trypsinization
twice a week. Human AB serum used in some transfections was purchased from Irvine Scienti¢c. For
transfection, 2U105 HeLa cells were seeded in 1 ml
of medium in 48-well culture plates (11.3 mm well
diameter, Costar, Acton, MA, USA) 24 h before
addition of the complexes and used at approximately
80% con£uency.
2.3. Liposome preparation
DOTAP/DOPE, DOTAP/cholesterol (1:1 molar
ratio) and DOTAP/DOPE/cholesterol (1:1:1 molar
ratio) liposomes were prepared by drying a chloroform solution of the lipids by rotary evaporation
under reduced pressure and then hydrating the ¢lm
with 1 ml of deionized water to a concentration of
5 mg total lipid/ml. The tube was vortexed for 1 min
and the suspension was diluted to a ¢nal concentration of 1 mg/ml of total lipid. The multilamellar
vesicles were extruded through polycarbonate membranes with 100 nm pore diameter, using a Liposofast device (Avestin, Toronto, Canada) to obtain a
uniform size distribution, and ¢lter-sterilized (Millex
0.45 Wm, Millipore, Bedford, MA, USA). The average diameter of the liposomes was 110 þ 30 nm.
Liposomes were stored at 4³C under argon and
were used within 1 month after preparation.
2.4. Preparation of lipoplexes
Complexes were prepared by sequentially mixing
100 Wl of a solution of 100 mM NaCl plus 20 mM
HEPES, pH 7.4, with or without 32 Wg of transferrin,
with 2, 4, 8 or 16 Wl of the liposome suspension and
incubated for 15 min at room temperature. One hundred microliters of HEPES bu¡er containing 1 Wg of
pCMVLacZ plasmid encoding L-galactosidase was
then added and gently mixed. Complexes were then
incubated for the time described in each experiment.
The lipid to DNA charge ratio was calculated as the
mole ratio of DOTAP (one charge per molecule) to
nucleotide residue (average MW 330).
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2.5. Transfection activity
Cells were washed twice with DME-HG without
serum and antibiotics and then 0.3 ml of this medium
and 0.2 ml of complexes were added gently to each
well. After a 4-h incubation (at 37³C in 5% CO2 ) the
medium was replaced with DME-HG containing
10% FBS and antibiotics and the cells were further
incubated for 48 h. If the lipofection was performed
in the presence of serum, non-heat-inactivated FBS
or human AB serum was added to the cells to a ¢nal
concentration as indicated in the experiments.
Cells were washed 48 h after transfection with
phosphate-bu¡ered saline (PBS) and lysed with
100 Wl of lysis bu¡er (0.25 M Tris, pH 8) at room
temperature for 10 min, followed by alternating
freeze^thaw cycles. The cell lysate was centrifuged
for 5 min at 10 000Ug to pellet debris. A 70-Wl
amount of the supernatant was assayed for total Lgal activity as described by Invitrogen (Carlsbad,
CA, USA) using an Emax plate reader (Molecular
Devices, Sunnyvale, CA, USA). The protein content
of the lysates was measured by the DC Protein Assay
reagent (Bio-Rad, Hercules, CA, USA) using bovine
serum albumin as the standard. The data were expressed as ng of L-gal (based on a standard curve for
L-galactosidase activity) per milligram of protein.
2.6. Transfection e¤ciency
Transfection e¤ciency was evaluated by scoring
the percentage of cells expressing L-galactosidase.
Cells transfected with 1 Wg of pCMVLacZ were
washed with PBS, ¢xed in a solution of 2% formaldehyde and 0.2% glutaraldehyde and stained with a
solution containing X-gal (5-bromo-4-chloro-3-indolyl-L-D-galactopyranoside) (1 mg/ml). The cells were
incubated at 37³C for 12 h and examined under a
phase contrast microscope for the development of
blue color. Quanti¢cation of transfected cells was
performed by counting the number of stained and
unstained cells in about 20 randomly selected ¢elds.
2.7. Cell viability assay
Cell viability was quanti¢ed by a modi¢ed Alamar
blue assay [44,45]. Brie£y, 1 ml of 10% (v/v) Alamar
blue dye in DME-HG supplemented with 10% (v/v)
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FBS medium was added to each well 48 h after
transfection. After 2.5 h of incubation at 37³C,
200 Wl of the supernatant was assayed by measuring
the absorbance at 570 and 600 nm. Cell viability (as
a percentage of control cells) was calculated according to the formula (A570 3A600 ) of treated cellsU100/
(A570 3A600 ) of control cells.
2.8. Particle size determinations
The size distribution of the lipoplexes was determined by dynamic light scattering in a Coulter N4
Plus Submicron Particle Analyzer (Coulter, Miami,
FL, USA) at 90³ with 2 min of calibration and 4 min
of run time. SDP analysis was performed using 17
bins. When DOTAP/DOPE liposomes were mixed
with the plasmid pCMVLacZ at di¡erent charge ratios (+/3) (0.5, 1, 2 and 4), the resultant plain complexes had size distributions of 193 þ 95, 328 þ 87,
190 þ 80 and 160 þ 70 nm, respectively. The size distributions of the Tf-complexes for the corresponding
charge ratios were 390 þ 135, 370 þ 131, 460 þ 136
and 600 þ 194 nm, respectively. Measurements were
carried out at least in duplicate immediately after
preparation of the complexes.
2.9. Zeta potential measurements
The overall charge of the complexes was examined
by zeta potential measurements using a Coulter Delsa 440 SX instrument (Coulter Electronics, Hialeah,
FL, USA). Samples of the prepared complexes were
placed in the measuring cell, whose position was adjusted to cover a previously determined stationary
layer, and an electric current of 3 mA was applied.
The zeta potential was calculated for each scattering
angle (8.6³, 17.1³, 25.6³ and 34.2³), and the values
described represent the mean from the di¡erent angles of two measurements.
3. Results
3.1. E¡ect of serum concentration on lipofection
activity
Transfection activity mediated by either plain or
Tf-lipoplexes, at di¡erent lipid/DNA (+/3) charge

Fig. 1. E¡ect of serum concentration on L-galactosidase gene
expression by HeLa cells transfected with plain DOTAP/DOPE
or transferrin lipoplexes immediately after preparation. The
data represent the mean þ S.D. of three wells and are representative of three independent experiments.

ratios, was examined as a function of serum concentration. The association of transferrin with cationic
liposomes composed of DOTAP and DOPE increased L-galactosidase expression both in the absence or presence of serum compared to lipoplexes
without transferrin (Fig. 1). In the absence of serum,
the e¡ect of the ligand was more prevalent for 1/2
and 1/1 (+/3) lipid/DNA complexes, where an enhancement of 14- and 11-fold was observed, respectively, compared to plain lipoplexes. L-Galactosidase
activity mediated by the positively charged complexes, 2/1 and 4/1 (+/3), was lower than that obtained with the negatively charged lipoplexes.
Expression of L-gal mediated by 1/2, 1/1 and 2/1
(+/3) Tf-lipoplexes was reduced as the serum concentration was increased. The inhibitory e¡ect of serum was diminished with increasing charge ratio
(+/3). For 4/1 (+/3) Tf-complexes, the inhibitory
e¡ect of serum was overcome, resulting in a similar
L-galactosidase activity in 60% FBS as the maximal
obtained for 1/1 (+/3) complexes in the absence of
serum. Transfection activity of 4/1 (+/3) Tf-com-
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itory e¡ect of serum was overcome by Tf-complexes
of 4/1 (+/3) charge ratio. Gene expression by plain
lipoplexes in serum was less than 0.2 ng L-galactosidase per milligram of total cell protein (data not
shown).
3.2. E¡ect of plain and Tf-lipoplexes on cell viability
in the absence or presence of serum
To evaluate whether transferrin and plain complexes at various lipid/DNA (+/3) charge ratios
were toxic to the cells, cell viability was assessed
following transfection. The Alamar blue assay
showed a viability higher than 90% in all transfected
wells (Fig. 3). The relative cytotoxicity of lipoplexes
was also assessed by the total amount of extractable
cellular proteins in the cell lysate per well and con¢rmed the results with the Alamar blue assay (data
not shown).
Fig. 2. Lipofection of HeLa cells by Tf^DOTAP/cholesterol
and Tf^DOTAP/DOPE/cholesterol lipoplexes in the absence
(3serum) or presence of 60% FBS (+serum) at di¡erent lipid/
DNA (+/3) charge ratios. The data represent the mean þ S.D.
of three wells and are representative of three independent experiments.

plexes in 60% FBS increased by 5-fold compared to
that in the absence of serum. Heat-inactivated sera
retained the potential to enhance Tf-lipoplex mediated transfection (data not shown). Gene delivery
and expression by plain lipoplexes even at the lowest
serum concentration used (20% FBS) was less than
0.2 ng L-galactosidase per milligram of total cell protein (data not shown). To determine whether the inhibitory e¡ect of serum by Tf-lipoplexes at low
charge ratios and enhancement at high charge ratios
is limited to DOTAP/DOPE liposomes, we examined
DOTAP/cholesterol and DOTAP/DOPE/cholesterol
complexes for sensitivity to 60% FBS at di¡erent
charge ratios (+/3) (Fig. 2). In the absence of serum
the highest level of transfection was observed at a 1/1
(+/3) charge ratio for DOTAP/cholesterol complexes
and at 1/1 and 2/1 charge ratios for DOTAP/DOPE/
cholesterol complexes. In the presence of serum, the
same e¡ect as in DOTAP/DOPE complexes was observed, namely that 60% serum inhibited transfection
by Tf-lipoplexes at low charge ratios, but the inhib-

Fig. 3. E¡ect of plain (P) and transferrin (Tf)^DOTAP/DOPE
lipoplexes on the viability of HeLa cells in the absence (3serum) or presence of 60% FBS (+serum) at di¡erent lipid/DNA
(+/3) charge ratios. Cell viability was expressed as the percentage of the untreated control cells. Data represent the
mean þ S.D. obtained from duplicate wells and are representative of two independent experiments.
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Table 1
Gene transfer e¤ciency (% of blue cells) by plain (DOTAP/DOPE) and Tf-lipoplexes containing pCMVLacZ in HeLa cells as a function of the charge ratio lipid/DNA (+/3), in the absence or presence of serum
Charge ratio (+/3)
0.5
1
2
4

Plain lipoplexes (3serum)
2^4
2^4
2^4
2^4

3.3. Evaluation of transfection e¤ciency
To investigate whether the enhancement of transfection mediated by the association of transferrin in
the absence or presence of serum was due to an increase in the number of cells transfected or only due
to an enhancement of gene expression, we evaluated
the transfection e¤ciency, de¢ned as the percentage
of cells that visibly express the L-galactosidase gene.
In the absence of serum, 1/1 (+/3) Tf-lipoplexes
showed the highest percentage of transfected cells
(12^15%). Transfection e¤ciency by Tf-lipoplexes in
the presence of 60% FBS was maximal for the 4/1
(+/3) charge ratio (10^12%) (Table 1). The number
of cells expressing L-galactosidase for plain lipoplexes in the presence of serum was less than 0.1%
(data not shown).

Tf-lipoplexes (% serum)
0

20

40

60

10^12
12^15
4^6
3^5

1^2
3^5
4^6
6^8

1^2
2^4
4^6
8^10

1^2
2^4
3^5
10^12

3.5. Maturation of Tf-lipoplexes enhances their serum
resistance
Tf-lipoplexes at di¡erent charge ratios (+/3) were
incubated for di¡erent lengths of time at 20³C and
examined for L-galactosidase activity and serum sensitivity. Transfection activity in the presence or absence of serum increased by prolonging the incubation time of the complexes. This e¡ect was even more
pronounced when the complexes were incubated with
the cells in 60% FBS (Fig. 4). After 6 h of incubation, the net negatively charged 1/1 (+/3) Tf-complex
became serum-resistant, that is, its transfection activity was not inhibited by serum. The positively
charged 2/1 (+/3) complexes overcame the inhibitory
e¡ect of serum after 30 min of incubation. Notice
that Tf-complexes used immediately after prepara-

3.4. Zeta potential of plain and Tf-complexes
We examined the overall charge of the complexes
at di¡erent (+/3) charge ratios by zeta potential
measurements. The values were in agreement with
what was expected from the theoretical calculations
based on their charge and the results reported by
Simo¬es et al. [42]. The association of transferrin
with DOTAP/DOPE/DNA complexes resulted in a
decrease of the surface charge for all the charge ratios tested. For example the zeta potential of the 1/1
(+/3) complexes decreased from 2 to 338 mV in the
presence of transferrin. This e¡ect is most likely due
to the negatively charged amino acids of the protein
interacting with the cationic liposomes.

Fig. 4. E¡ect of the incubation time of Tf^DOTAP/DOPE lipoplexes on serum resistance. Complexes were prepared at di¡erent lipid/DNA (+/3) charge ratios (triangles, 1/1, squares, 2/1,
circles, 4/1) and incubated at 20³C for the lengths of time described in the ¢gure. Lipofection of HeLa cells was performed
in the absence (open symbols) or presence of 60% FBS (¢lled
symbols). The data represent the mean þ S.D. of three wells and
are representative of three independent experiments.
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Fig. 5. E¡ect of speci¢c competition for transferrin receptors
on gene transfer by transferrin lipoplexes. An excess of free
transferrin (10 mg/ml) was added to the cells prior the addition
of the Tf-lipoplexes at the 4/1 (+/3) charge ratio. Data represent the mean þ S.D. obtained from duplicate wells and are representative of two independent experiments.

tion were serum-sensitive even at a charge ratio of
2/1 (+/3) (Fig. 1). Complexes incubated for 6 h also
mediated e¤cient transfection in the presence of human serum (60%) (data not shown), indicating that
the phenomenon is not speci¢c to fetal bovine serum.
3.6. Speci¢city of targeting to the transferrin receptor
To explore whether the uptake of Tf-lipoplexes is
facilitated via interaction with the transferrin-receptor, a competitive inhibition experiment was performed, using 4/1 (+/3) lipoplexes which give the
highest level of transfection in serum. Treatment of
the cells with a large excess of iron-saturated transferrin in the medium (10 mg/ml), representing 156
times the amount of transferrin associated with lipoplexes, led to a decrease in the level of transfection
mediated by Tf-lipoplexes (Fig. 5).
4. Discussion
One of the possible reasons for the relatively low
gene expression often obtained by lipoplexes is the
ine¤cient entry of the lipid^DNA complex into the
cells. Previous studies have shown that the associa-
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tion of a targeting ligand, transferrin, with lipoplexes
enhances the transfection of cell lines [42,46] and
primary cells [43]. The expression of transferrin receptors is particularly high on proliferating malignant cells, as compared with the corresponding normal ones, making this receptor an attractive target
for cancer gene therapy [47]. Transferrin^polylysine
conjugates were shown to be targeted to cellular
transferrin receptors [4,24^26,48,49]; however, these
molecular conjugates have low transfection e¤ciency.
Our results indicate that Tf-lipoplexes always mediate higher gene expression compared to plain lipoplexes in the absence or presence of serum (Fig. 1).
Conditions which enhance transfection activity also
enhance transfection e¤ciency, although the percentage of enhancement cannot be directly correlated
(Table 1). DOTAP/DOPE liposomes bind transferrin
through the negatively charged groups present in the
ligand at physiological pH, and the resulting structure forms a complex with DNA through a charge^
charge interaction. Association of transferrin with
DOTAP/DOPE/DNA complexes appears to facilitate
the internalization of the complex due to the ability
of the ligand to stimulate endocytosis. The competitive inhibition of transfection by excess free transferrin supports the hypothesis that the Tf-complexes
are recognized by transferrin receptors on the cell
surface, which in turn facilitate receptor-mediated
endocytosis (Fig. 5). Further experiments with antiTf receptor antibodies or receptor-de¢cient cells will
be necessary to con¢rm this hypothesis. Interestingly,
previous experiments with 1/1 and 2/1 (+/3) Tf-lipoplexes and 8 mg free transferrin indicated no signi¢cant inhibition of transfection activity, suggesting
non-speci¢c endocytosis of these complexes [50].
The inhibitory e¡ect of serum on transfection
mediated by lipoplexes has been reported for di¡erent cell types [28,37,51] and represents a serious limitation for their use in vivo. One important element
in emulating in vivo conditions is the use of high
concentrations of serum for transfection experiments
in vitro, rather than serum-free medium, which optimizes transfection. So far, most of the studies on the
e¡ect of serum on transfection reported have been
carried out in the presence of at most 20% serum
[52], a condition that is far from that found in vivo.
The lower level of gene expression by net positively
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charged (2/1 and 4/1) (+/3) Tf-lipoplexes compared
to the net negatively charged (1/2 and 1/1) (+/3)
complexes in the absence of serum, may be related
to a `masking' of the ligand by an excess of positive
charge, thus decreasing the e¤ciency of transferrin to
recognize its receptor. The di¡erence in transfection
activity between these sets of complexes cannot be
explained by di¡erent toxicities of the formulations
or of the serum, since cell viability was similar in
both cases (Fig. 3). It is also possible that the negatively charged Tf-lipoplexes dissociate more readily
once inside the cell, as suggested by observations on
plain lipoplexes [53].
For complexes with low charge ratios (1/2 and 1/1)
(+/3), increasing the concentration of serum inhibited gene delivery and expression (Fig. 1). This inhibitory e¡ect was minimal for the 2/1 (+/3) complexes.
At the 4/1 (+/3) charge ratio; however, the inhibitory e¡ect of serum on transfection was overcome.
The molecular mechanism by which the inhibitory
e¡ect of serum is overcome is not known. It is possible that the charge neutralizing e¡ect of the negatively charged macromolecules present in serum is
countered by an excess of positive charge on the
Tf-lipoplexes. Although the charge ratio of DC-cholesterol liposomes to DNA has been shown previously to be critical for high e¤ciency of lipofection
[54], and it is known that the inhibitory e¡ect of
serum can be overcome by increasing the charge ratio of cationic liposome to DNA [55], it should be
mentioned that the concentration of serum used in
these experiments was only 20%. An excess of positive charge, however, is not su¤cient to explain the
superior performance of the Tf-lipoplexes compared
to plain lipoplexes, since the latter do not have signi¢cant transfection activity although they are more
positively charged compared to Tf-lipoplexes. In Tflipoplexes, the transferrin molecule, in addition to
acting as a ligand, also neutralizes part of the positive charge on the liposomes, leading to diminished
interactions with polyanionic molecules in serum.
Consequently, complexes resistant to higher concentrations of serum can be prepared. It is also interesting to note that increasing amounts of serum increased transfection levels. The reasons for this
increase are not clear at present. The enhancement
of Tf-lipoplex-mediated gene transfer by high concentrations of serum was also observed for DO-

TAP/cholesterol and DOTAP/DOPE/cholesterol
liposomes, indicating that this e¡ect is not speci¢c
for DOTAP/DOPE (Fig. 2). The transfection activity
mediated by plain lipoplexes was almost completely
inhibited by serum ( 6 0.2 ng L-galactosidase/mg protein). Non-speci¢c interactions of plain lipoplexes
with the negatively charged macromolecules in serum
most likely prevent their binding to the cells, while
Tf-lipoplexes can interact with cell surface receptors.
Relatively prolonged incubation of negatively
charged Tf-complexes 1/1 (+/3) before addition to
the cells rendered them serum-resistant, suggesting
that maturation of the complex is an essential element of serum-resistance (Fig. 4). A recent study has
shown the resistance to 20% FBS of DC-cholesterol
lipoplexes at 2/1 (+/3) charge ratio, after 50 min of
incubation [56]. The time at which the Tf-lipoplexes
turned from serum-sensitive to serum-resistant was
di¡erent depending on the charge ratio. Positively
charged 2/1 (+/3) Tf-lipoplexes were serum-resistant
after 30 min of incubation. Note that in the case of
complexes used immediately after preparation only
the ones prepared at 4/1 (+/3) charge ratio were
serum-resistant (Fig. 1). Although the increase in
size by increasing the incubation time can have
some e¡ect on the level of transfection [57], the development of a di¡erent structure more resistant to
serum in these mature Tf-lipoplexes is likely to be
another reason by which the transfection activity is
enhanced.
In summary, our study has established the role of
the charge ratio and the time of complex maturation
in serum-resistance and enhancement of transfection
by Tf-lipoplexes in the presence of high concentration of serum (up to 60% FBS). Our results indicate
that Tf-lipoplexes, either net negatively or positively
charged, remain e¡ective despite any possible interaction with serum components. We believe that this
fact will be of bene¢t to gene delivery and gene therapy in vivo. Our laboratory is currently investigating
how Tf-lipoplexes deliver DNA into cells and
whether they can also enhance transfection in vivo.
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